ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 20 Issue : 1
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
Use of covered stents in simultaneous management of coarctation of the aorta and patent ductus arteriosus [Anatol J Cardiol]
Anatol J Cardiol. 2018; 19(4): 232-236 | DOI: 10.14744/AnatolJCardiol.2018.61257  

Use of covered stents in simultaneous management of coarctation of the aorta and patent ductus arteriosus

Emine Hekim Yilmaz1, Mustafa Orhan Bulut1, Mehmet Küçük1, Ilker Kemal Yücel1, Abdullah Erdem2, Ahmet Çelebi1
1Department of Pediatric Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital; İstanbul-Turkey
2Department of Pediatric Cardiology, Medipol University Hospital; İstanbul-Turkey

Objective: To report clinical and procedural characteristics of twelve patients who received a covered stent for the treatment of aortic coarctation and concurrent patent ductus arteriosus (PDA).
Methods: A single center database was retrospectively evaluated to obtain data of patients with combined aortic coarctation and PDA. We selected patients in whom a covered stent was used for the treatment of both pathologies. The stent length was chosen so as to cover the entire length of the lesion from healthy to healthy tissue and also cover the ampulla of PDA.
Results: The median age of the patients was 15 (range, 6.5-35) years. The diameter of the coarctated segment increased from a median of 8.4 (range, 2.6-10.8) mm to 16 (range, 9-24) mm (p<0.005), whereas the pressure gradient decreased from a median of 43 (range, 10-71) mm Hg to 0 (range, 0-8) mm Hg (p<0.005). Fourteen covered stents were used for 12 patients. Following deployment, seven stents were flared with larger and low-pressure balloons because of the gap between the distal end of the stent and the poststenotic dilated segment of the aorta, which caused residual PDA shunts and/or instability of the stent. After the procedure, no residual PDA shunt was present in any patient.
Conclusion: To the best of our knowledge, this study includes the largest series of patients reported in literature in whom covered CP stents were used for simultaneous percutaneous treatment of coarctation and PDA. The procedure was successful and stable results were obtained during follow-up in all cases.

Keywords: aortic coarctation, patent ductus arteriosus, covered stent


Emine Hekim Yilmaz, Mustafa Orhan Bulut, Mehmet Küçük, Ilker Kemal Yücel, Abdullah Erdem, Ahmet Çelebi. Use of covered stents in simultaneous management of coarctation of the aorta and patent ductus arteriosus. Anatol J Cardiol. 2018; 19(4): 232-236

Corresponding Author: Ilker Kemal Yücel, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2018 Turkish Society of Cardiology